Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Internal Medicine · LA CROSSE, WI · NPI 1164911442
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 425 | 121 |
| Lisinopril | Lisinopril | 320 | 85 |
| Metoprolol Succinate | Metoprolol Succinate | 242 | 72 |
| Omeprazole | Omeprazole | 227 | 60 |
| Eliquis | Apixaban | 152 | 37 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 150 | 42 |
| Amlodipine Besylate | Amlodipine Besylate | 141 | 46 |
| Losartan Potassium | Losartan Potassium | 140 | 43 |
| Hydrochlorothiazide | Hydrochlorothiazide | 139 | 45 |
| Tamsulosin Hcl | Tamsulosin Hcl | 136 | 42 |
| Metformin Hcl Er | Metformin Hcl | 133 | 38 |
| Furosemide | Furosemide | 128 | 28 |
| Simvastatin | Simvastatin | 122 | 30 |
| Metoprolol Tartrate | Metoprolol Tartrate | 117 | 31 |
| Gabapentin | Gabapentin | 112 | 26 |
| Levothyroxine Sodium | Levothyroxine Sodium | 102 | 26 |
| Allopurinol | Allopurinol | 99 | 29 |
| Metformin Hcl | Metformin Hcl | 99 | 22 |
| Trulicity | Dulaglutide | 97 | 16 |
| Pantoprazole Sodium | Pantoprazole Sodium | 68 | 20 |
| Trazodone Hcl | Trazodone Hcl | 68 | 16 |
| Warfarin Sodium | Warfarin Sodium | 62 | 14 |
| Glimepiride | Glimepiride | 61 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 57 | 16 |
| Clopidogrel | Clopidogrel Bisulfate | 51 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 48 | 24 |
| Xarelto | Rivaroxaban | 48 | 11 |
| Entresto | Sacubitril/Valsartan | 46 | 11 |
| Sertraline Hcl | Sertraline Hcl | 44 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 43 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 43 | suppressed |
| Spironolactone | Spironolactone | 43 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 38 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 35 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 34 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 34 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 34 | suppressed |
| Nitroglycerin | Nitroglycerin | 32 | 26 |
| Finasteride | Finasteride | 31 | 11 |
| Bupropion Xl | Bupropion Hcl | 30 | suppressed |
| Chlorthalidone | Chlorthalidone | 29 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 29 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 28 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 28 | 11 |
| Bumetanide | Bumetanide | 27 | 11 |
| Memantine Hcl | Memantine Hcl | 27 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 27 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 27 | suppressed |
| Famotidine | Famotidine | 26 | suppressed |
| Pregabalin | Pregabalin | 26 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 23 | suppressed |
| Prednisone | Prednisone | 22 | 17 |
| Carvedilol | Carvedilol | 21 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 21 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 21 | 11 |
| Amantadine | Amantadine Hcl | 20 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 20 | suppressed |
| Potassium Chloride | Potassium Chloride | 20 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 19 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 18 | 18 |
| Valsartan | Valsartan | 18 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 17 | suppressed |
| Nystatin | Nystatin | 17 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 17 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 17 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 16 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 16 | suppressed |
| Jardiance | Empagliflozin | 16 | suppressed |
| Levetiracetam | Levetiracetam | 16 | suppressed |
| Baclofen | Baclofen | 15 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 15 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 15 | suppressed |
| Nifedipine Er | Nifedipine | 15 | suppressed |
| Amoxicillin | Amoxicillin | 14 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 14 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 14 | suppressed |
| Ozempic | Semaglutide | 14 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 14 | suppressed |
| Alprazolam | Alprazolam | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 13 | suppressed |
| Loperamide | Loperamide Hcl | 13 | suppressed |
| Lorazepam | Lorazepam | 13 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Ezetimibe | Ezetimibe | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error